Effect of changing breast cancer incidence rates on the calibration of the Gail model

Journal of Clinical Oncology

Volumn 28, Issue 14, 2010, Pages 2411-2417

  Schonfeld, Sara J ^a   Pee, David ^a   Greenlee, Robert T ^a   Hartge, Patricia ^a   Lacey Jr , James V ^a   Park, Yikyung ^a   Schatzkin, Arthur ^a   Visvanathan, Kala ^a   Pfeiffer, Ruth M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

RALOXIFENE; TAMOXIFEN; TAMOXIFEN CITRATE;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST HYPERPLASIA; CALIBRATION; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER INVASION; CANCER MODEL; CANCER RISK; CAUCASIAN; CLINICAL TRIAL (TOPIC); FAMILY HISTORY; FEMALE; GAIL MODEL; GROUPS BY AGE; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MATERNAL AGE; MENARCHE; MORTALITY; MULTICENTER STUDY (TOPIC); POSTMENOPAUSE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; VALIDATION STUDY; AGE; AGE DISTRIBUTION; BREAST TUMOR; CANCER REGISTRY; CLINICAL TRIAL; DECISION SUPPORT SYSTEM; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PATIENT SELECTION; PROPORTIONAL HAZARDS MODEL; REPRODUCIBILITY; STATISTICAL MODEL; TIME; UNITED STATES;

AGE DISTRIBUTION; AGE FACTORS; BREAST NEOPLASMS; CALIBRATION; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM INVASIVENESS; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SEER PROGRAM; TIME FACTORS; UNITED STATES;

EID: 77952529935     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.25.2767     Document Type: Article

References (22)

1. Gail MH, Brinton LA, Byar DP, et al: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879-1886, 1989
2. Costantino JP, Gail MH, Pee D, et al: Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 91:1541-1548, 1999 (Pubitemid 29457958)
3. Fisher B, Costantino JP, Wickerham DL, et al: Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 90:1371-1388, 1998 (Pubitemid 28439961)
4. Vogel VG, Costantino JP, Wickerham DL, et al: Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial. JAMA 295:2727-2741, 2006
5. Visvanathan K, Chlebowski RT, Hurley P, et al: American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. J Clin Oncol 27:3235-3258, 2009
6. Gail MH, Pfeiffer RM: On criteria for evaluating models of absolute risk. Biostatistics 6:227-239, 2005 (Pubitemid 41240355)
7. Gail MH, Costantino JP, Bryant J, et al: Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst 91:1829-1846, 1999
8. Freedman AN, Graubard BI, Rao SR, et al: Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst 95:526-532, 2003 (Pubitemid 36511623)
9. Bondy ML, Lustbader ED, Halabi S, et al: Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst 86:620-625, 1994 (Pubitemid 24143172)
10. Rockhill B, Spiegelman D, Byrne C, et al: Validation of the Gail, et al: Model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 93:358-366, 2001 (Pubitemid 32229380)
11. Pankratz VS, Hartmann LC, Degnim AC, et al: Assessment of the accuracy of the Gail model in women with atypical hyperplasia. J Clin Oncol 26:5374-5379, 2008
12. Chlebowski RT, Anderson GL, Lane DS, et al: Predicting risk of breast cancer in postmenopausal women by hormone receptor status. J Natl Cancer Inst 99:1695-1705, 2007 (Pubitemid 351767220)
13. Glass AG, Lacey JV Jr, Carreon JD, et al: Breast cancer incidence, 1980-2006: Combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 99:1152-1161, 2007
14. Ravdin PM, Cronin KA, Howlader N, et al: The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356:1670-1674, 2007
15. Clarke CA, Glaser SL, Uratsu CS, et al: Recent declines in hormone therapy utilization and breast cancer incidence: Clinical and population-based evidence. J Clin Oncol 24:e49-e50, 2006
16. Schatzkin A, Subar AF, Thompson FE, et al: Design and serendipity in establishing a large cohort with wide dietary intake distributions: The National Institutes of Health-American Association of Retired Persons Diet and Health study. Am J Epidemiol 154:1119-1125, 2001 (Pubitemid 33140635)
17. Prorok PC, Andriole GL, Bresalier RS, et al: Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 21:273S-309S, 2000
18. Doody MM, Freedman DM, Alexander BH, et al: Breast cancer incidence in U.S. radiologic technologists. Cancer 106:2707-2715, 2006
19. Schairer C, Byrne C, Keyl PM, et al: Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States). Cancer Causes Control 5:491-500, 1994 (Pubitemid 24335711)
20. Surveillance, Epidemiology, and End Results (SEER): SEER Stat Database Incidence, SEER 9 Regs Limited-Use, 1973-2005: Katrina/Rita Population Adjustment Linked to County Attributes in Total United States, 1969-2005. Bethesda, MD, National Cancer Institute, DCCPS, Cancer Statistics Branch, released April 2008, based on November 2007 submission
21. Surveillance, Epidemiology, and End Results (SEER): SEER Stat Database Incidence, SEER 13 Regs Limited-Use, 1992-2005: Katrina/Rita Population Adjustment Linked to County Attributes in Total United States, 1969-2005. Bethesda, MD, National Cancer Institute, DCCPS, Cancer Statistics Branch, released April 2008, based on November 2007 submission
22. Gail MH, Costantino JP, Pee D, et al: Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst 99:1782-1792, 2007 (Pubitemid 351767204)